Eisai Co., Ltd. (ESALF)
OTCMKTS · Delayed Price · Currency is USD
32.75
+0.56 (1.74%)
Sep 2, 2025, 2:23 PM EDT
Eisai Market Cap
Eisai has a market cap or net worth of $8.91 billion as of September 2, 2025. Its market cap has decreased by -16.63% in one year.
Market Cap
8.91B
Enterprise Value
8.76B
Revenue
5.57B
Ranking
n/a
PE Ratio
25.54
Stock Price
$32.75
Market Cap Chart
Since January 14, 1992, Eisai's market cap has increased from 3.15B to 8.91B, an increase of 182.94%. That is a compound annual growth rate of 3.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 8.97B | 15.47% |
| Dec 30, 2024 | 7.76B | -45.93% |
| Dec 29, 2023 | 14.36B | -24.17% |
| Dec 30, 2022 | 18.94B | 16.45% |
| Dec 30, 2021 | 16.26B | -20.50% |
| Dec 30, 2020 | 20.45B | -5.28% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 832.17M |
| Elite Pharmaceuticals | 734.61M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 655.63M |
| Northwest Biotherapeutics | 448.50M |
| CytoDyn | 376.00M |
| American Oncology Network | 343.87M |